Skip to content
Olverembatinib dimesylate

Olverembatinib dimesylate

Regular price $126.50 USD
Sale price Regular price

THE SCIENCE, IN DETAIL

Know your product.

Specifications
Bioactivity
Olverembatinib (GZD824) dimesylate is a third-generation oral effective BCR-ABL inhibitor, acting on BCR-ABL (WT) and BCR-ABL (T315I) with IC50 of 0.34 nM and 0.68 nM, respectively.
Casnumber
1421783-64-3
Formula
C29H27F3N6O.2CH4O3S
Mw
724.77
Psmiles
CN1CCN(CC1)CC2=C(C=C(NC(=O)C3=CC(=C(C)C=C3)C#CC4=CC5=C([NH]N=C5)N=C4)C=C2)C(F)(F)F.C[S](O)(=O)=O.C[S](O)(=O)=O
Purity
99.30%
Solubility
DMSO 90 mg/mL; Water 40 mg/mL
Target synonyms
GZD824 dimesylate; HQP1351 dimesylate
Technical documents

Documents

A PARTNER IN YOUR RESEARCH

More time for discovery. Less time sourcing.

Bring your laboratory requirements together with scientific advice, global sourcing and dedicated procurement support.

Explore our services

Starting a new laboratory?

Plan your laboratory with our New-Lab programme.

Discover New-Lab